Avacta Group Plc (AVCT)-Product Pipeline Analysis, 2016 Update

Avacta Group Plc (AVCT)-Product Pipeline Analysis, 2016 Update


  • Products Id :- GDME16609PD
  • |
  • Pages: 30
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Avacta Group Plc (Avacta) is a healthcare company that offers technology services. The company provides proprietary solutions to the life sciences and healthcare sector. It offers products such as optim and sensipod. Avacta has also developed UCB celltech, which is an analytical instrument. The company's sensipod is an in-clinical blood testing system that delivers ELISA tests. It provides intellectual property relating to an alternative to antibodies. The company's technology is engineered as an alternative to antibodies and aptamers. It caters to life science researchers. Avacta is headquartered in Wetherby, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Avacta Group Plc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Avacta Group Plc Company Snapshot 6

Avacta Group Plc Company Overview 6

Avacta Group Plc Pipeline Products and Clinical Trials Overview 7

Avacta Group Plc-Pipeline Analysis Overview 9

Key Facts 9

Avacta Group Plc-Major Products and Services 10

Avacta Group Plc Pipeline Products by Development Stage 11

Avacta Group Plc Pipeline Products Overview 13

Depression Test 13

Depression Test Product Overview 13

Diagnostic Assay-Alzheimer's Disease 14

Diagnostic Assay-Alzheimer's Disease Product Overview 14

Diagnostic Test-ADHD 15

Diagnostic Test-ADHD Product Overview 15

Diagnostic Test-Bipolar Disorder 16

Diagnostic Test-Bipolar Disorder Product Overview 16

Portable Pathogen Detection System 17

Portable Pathogen Detection System Product Overview 17

Schizophrenia Response Test 18

Schizophrenia Response Test Product Overview 18

Schizophrenia Side Effects Test 19

Schizophrenia Side Effects Test Product Overview 19

Avacta Group Plc-Key Competitors 20

Avacta Group Plc-Key Employees 21

Avacta Group Plc-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Avacta Group Plc, Recent Developments 23

Jun 22, 2016: Avacta Rapidly Generates Affimer Binders for Zika Virus Diagnostics 23

Apr 25, 2016: Avacta Group: Interim Results for the Period Ended 31 January 2016 23

Apr 19, 2016: Affimer Therapeutic Platform Development Milestone Achieved 24

Jan 25, 2016: Avacta Appoints Philippe Cotrel as Chief Commercial Officer 25

Jul 07, 2015: Avacta Group announces Board Change 25

Oct 16, 2014: Avacta Group Provides Year end Results 25

Sep 30, 2014: Avacta Group Announces Affimer On-line Catalogue Launch 27

Jun 02, 2014: Avacta secures funding award to develop Affimers for therapeutic out-licensing 27

Apr 23, 2014: Avacta Group Announces Interim Results 28

Mar 20, 2014: Affimers Announces Technical and Commercial Update 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30

List of Figures

Avacta Group Plc Pipeline Products by Equipment Type 8

Avacta Group Plc Pipeline Products by Development Stage 11

List of Tables

Avacta Group Plc Pipeline Products and Clinical Trials Overview 7

Avacta Group Plc Pipeline Products by Equipment Type 7

Avacta Group Plc Pipeline Products by Indication 8

Avacta Group Plc, Key Facts 9

Avacta Group Plc, Major Products and Services 10

Avacta Group Plc Number of Pipeline Products by Development Stage 11

Avacta Group Plc Pipeline Products Summary by Development Stage 12

Depression Test-Product Status 13

Depression Test-Product Description 13

Diagnostic Assay-Alzheimer's Disease-Product Status 14

Diagnostic Assay-Alzheimer's Disease-Product Description 14

Diagnostic Test-ADHD-Product Status 15

Diagnostic Test-ADHD-Product Description 15

Diagnostic Test-Bipolar Disorder-Product Status 16

Diagnostic Test-Bipolar Disorder-Product Description 16

Portable Pathogen Detection System-Product Status 17

Portable Pathogen Detection System-Product Description 17

Schizophrenia Response Test-Product Status 18

Schizophrenia Response Test-Product Description 18

Schizophrenia Side Effects Test-Product Status 19

Schizophrenia Side Effects Test-Product Description 19

Avacta Group Plc, Key Employees 21

Avacta Group Plc, Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Source BioScience (Healthcare) Limited

Lidco Group Plc

Haemair Limited

GlySure Ltd

Avacta Group Plc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 48570
Site License
USD 1500 INR 97140
Corporate User License
USD 2250 INR 145710

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com